Manufacturing

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Articles

Evolving industry demands are driving the need for greater flexibility and innovation in processing equipment for pharmaceutical manufacturing.

Increasing Processing Flexibility to Meet Demand

The Cell Shuttle platform will manufacture cell therapies for its first clinical trials by the end of the year.

Cellares Set to Launch Good Manufacturing Practice–Compliant Cell Shuttle Manufacturing Platform

Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

Videos

Cellares CEO Fabian Gerlinghaus shares how an automated, closed-production platform with a small footprint can dramatically impact cost savings and scalability for cell and gene therapies.

Cellares Innovates With Automated Cell and Gene Therapy Platform

Biosynth has further strengthened its peptide division with the acquisition of  Pepceuticals.

Biosynth Strengthens Position in Peptide Field through Pepceuticals Acquisition

Manufacturers must figure out how flexible they need to be to meet the numerous new requirements of the changing therapeutic and regulatory landscapes.

Facing the Future of Aseptic Manufacturing

This agreement is intended to be executed and see the impact of any financial transfers by the fiscal year ending March 31, 2024.

Astellas Pharma to Transfer Manufacturing Plant, Business to Delpharm 

The new CGMP facility is expected to contribute to the development of mRNA therapeutics, with a building designed for the CGMP manufacture of mRNA-based in-vivo gene editing, gene-edited cell therapies, protein replacement therapies, cancer vaccines, and infectious disease vaccines.

TriLink BioTechnologies to Expand Manufacturing Capabilities 

Forge will provide adeno-associated virus (AAV) process development, toxicology, cGMP manufacturing, and analytical services to Life Bio, which will occur at Forge’s gene therapy facility in Columbus, Ohio called the Hearth.

Life Biosciences, Forge Biologics Partner for Manufacturing to Advance Gene Therapies

Engineering Research Center for Structured Organic Particulate Systems (ERC-SOPS), Department of Chemical and Biochemical Engineering, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.

Advanced continuous manufacturing with modular components is emerging as a preferred platform to produce APIs.

Advanced Continuous Manufacturing of Drugs

The new agreement is based off the Master Services Agreement that both companies entered in 2021 for the development, manufacture, and supply of rhenium (186Re) obisbemeda, according to a press release.

Manufacturing Services